US makes new Alzheimer's drug more widely accessible
Approximately 6.5 million Americans suffer from Alzheimer's, which is characterized by memory loss and declining mental acuity.
PREMIUMHealth
A carer helps an elderly resident - one of three Alzheimer sufferers in the establishment- in a house at L'Hay-les- Roses on the outskirts of Paris / AFP/File
By NewVision Reporter
Journalists @NewVision
#Alzheimer #US #Drug #Food and Drug Administration
The US drug regulator gave full approval to a new Alzheimer's medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for
Login to begin your journey to our premium content